![Jung Eun-kyung, head of the Central Defense Countermeasure Headquarters (Director of the Centers for Disease Control), is giving a regular briefing at the Centers for Disease Control in Cheongju, Chungbuk on the afternoon of the 1st, including the domestic outbreak of coronavirus infection (Corona 19) and the results of interim investigations of confirmed patients. [사진 출처 = 연합 뉴스]](https://i0.wp.com/file.mk.co.kr/meet/neds/2021/02/image_readtop_2021_104889_16121597754526957.jpg?w=560&ssl=1)
Jung Eun-kyung, head of the Central Defense Countermeasure Headquarters (Director of the Centers for Disease Control), is giving a regular briefing at the Centers for Disease Control in Cheongju, Chungbuk on the afternoon of the 1st, including the domestic outbreak of coronavirus infection (Corona 19) and the results of interim investigations of confirmed patients. [사진 출처 = 연합 뉴스]The vaccine produced by the US pharmaceutical company Janssen showed an average of 66% prevention rate in phase 3 clinical trials. Accordingly, Jung Eun-kyung, head of the Centers for Disease Control and Prevention, said that the Janssen vaccine was relatively ineffective compared to other vaccines, but emphasized that it has many advantages, such as distribution at room temperature and one dose.
At a regular briefing on Corona 19 on the 1st, Jung Eun-kyung said, “66% of the Janssen vaccines are relatively ineffective compared to other vaccines. The advantage of Janssen vaccines is that it can be distributed at room temperature of 2 to 8 degrees Celsius. “I said.
“The World Health Organization (WHO) sets the standard for the effectiveness of the vaccine at around 50%, and influenza vaccines are also vaccinated with about 40-60% effectiveness,” he said. “(Jansen vaccine) He emphasized that there is an advantage that this level of effect was achieved with one vaccination.
“If you keep the vaccine at -20 degrees Celsius, you can keep it for up to 24 months,” he said. “After carefully reviewing the advantages, disadvantages and effects, we will deliberate and decide on the appropriate person subject to vaccination through a special committee for vaccination review. “He said.
Korea has signed a contract for 6 million Janssen vaccines and is expected to be introduced in Korea from the second quarter. The preventive effect is somewhat inferior to Pfizer vaccine (95%), Modena (94.1%), and NovaVax (89.3%).
[맹성규 매경닷컴 기자 [email protected]]
[ⓒ 매일경제 & mk.co.kr, 무단전재 및 재배포 금지]